# Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients

> **NCT00470340** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 263 (actual)

## Conditions studied

- Liver Neoplasms
- Liver Cirrhosis
- Carcinoma, Hepatocellular
- Recurrence
- Neoplasm Recurrence, Local

## Interventions

- **DRUG:** Oxaliplatin, gemcitabine, cisplatin, lipiodol

## Key facts

- **NCT ID:** NCT00470340
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 263 (ACTUAL)
- **Why stopped:** during the study
- **Last updated:** 2011-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470340, "Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00470340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*